what are the main neurotransmitters of the CNS?
|
what is the function of each in the CNS?
|
GABA
|
mediates majority of inhibitory post-synaptic potentials
|
serotonin
|
control of appetite, sleep, mood, hallucinations, pain perception and vomiting
|
noradrenaline
|
increases arousal and alertness
|
Drugs that treat Anxiety
|
what is anxiety characterised by?
|
what is thought to be the pathophysiology of anxiety?
|
what neurotransmitters are anxiety symptoms mediated by?
|
a feeling of dread, apprehension or uneasiness that often arises from an unknown source
|
involves neurochemical dysfunction (e.g. decreased GABA-ergic tone, increased cortisol expression) and/or dysfunction of the amygdala in the brain
|
GABA
|
serotonin
|
noradrenaline
|
dopamine
|
what are the two main drug types that are used to treat anxiety?
|
what is an example of each of these drug types?
|
what is their mechanism of action?
|
benzodiazepines
|
diazepam, lorazepam, etc
|
binding to allosteric site of GABA-A receptors to enhance GABA binding
|
barbiturates
|
phenobarbitone, amobarbitone, etc
|
Drugs that treat Depression
|
what is depression characterised by?
|
what is thought to be the pathophysiology of depression?
|
what is the aims of pharmacological treatment of depression?
|
low mood, lack of motivation and interest, and aversion to activity
|
insufficient monoamine neurotransmitter activity
|
restore monoamine neurotransmitter activity
|
what are the drug types used to treat depression?
|
what is an example of each of these drug types?
|
what is their mechanism of action?
|
SSRIs (selective serotonin reuptake inhibitors)
|
escitalopram, sertraline, etc
|
selectively blocks the reuptake of serotonin back into the pre-synaptic cell, meaning that free serotonin stays in the synaptic gap longer and may bind again to serotonin receptors
|
SNRIs (serotonin-noradrenaline reuptake inhibitors)
|
venlafaxine, desvenlafaxine, etc
|
blocks the reuptake of serotonin and noradrenaline back into the pre-synaptic cell, meaning that both neurotransmitters stay in the synaptic gap longer and may bind again to their receptors
|
TCAs (tricyclic antidepressants)
|
amitriptyline, amoxapine, etc
|
blocks the reuptake of serotonin and noradrenaline back into the pre-synaptic cell
|
inhibits serotonin, sigma, muscarinic, NMDA and histamine receptors
|
MAOIs (monoamine oxidase inhibitors)
|
pirlindole, selegiline, etc
|
inhibits the activity of monoamine oxidase A and/or B, preventing the enzymes from breaking down monoamine neurotransmitters, increasing their availability
|